Increasing the production output and efficiency of a pharma manufacturing plant is the talk of the town nowadays, and it is the main purpose of innovation and investment in this sector. While patient needs, fighting new diseases, and saving lives have been the core principles, the strict competition is also becoming intense for many reasons, which we will discuss later in this article.
For these reasons and many more, the pharmaceutical industry must adopt innovative ways to increase productivity and face challenges. It also adds additional benefits to the organization such as increased market share, customer trust and global recognition.
Before we dig into how to increase productivity for the pharmaceutical industry, let's discuss why it is necessary to increase the productivity output of the pharmaceutical industry.
Why to increase production
Some challenges that are worth noting are described in this section
Increased regulatory expertise
Regulatory compliance has been the main concern for the pharmaceutical industry for many reasons, and it has increased in today's landscape.
Nowadays, the regulatory industry is well-informed about every advancement in every sector of the pharma manufacturing and has increased the capability of its inspectors in many ways, such as through training and expertise.
The regulatory industry is now well-versed with the new challenges and diseases for which pharma manufacturing operates.
The increased regulatory expertise has made it difficult for the pharma industry to bypass non-compliance. The regulatory bodies can now provide guidelines given the latest diseases and drug manufacturing challenges.
Additionally, there has been an increased trend of pharma companies fulfilling regulatory compliance, especially in third-world countries. These countries are now well-versed in the latest regulatory guidelines, have the desired investment, required expertise to handle these regulations. Among other advantages, increased compliance has enabled them to market their products in competitive first-world countries. As a result, the competition has increased for traditional pharma manufacturing organizations and reduced their market share & revenue-earning streams.
Dynamic operational challenges
The operational pharma industry faces many challenges that often cannot be predicted and changed. These challenges are dependent on the production rate and type. Some challenges are：
Energy Cost
Energy is the biggest contributor to the expense of any manufacturing industry. As its consumption increases, it disturbs the equilibrium of the balance sheet. The same is the case with the pharmaceutical industry, and in some cases, it is a major contributor since critical requirements cannot be provided without consuming energy sources.
Utilities such as HVAC, Compressed Air, and Steam consume a major portion of the energy requirement of the pharma industry.
In some cases, these utilities needs to be continuously provide to the required department for many reasons,, such as to maintain the required cleanliness level and prevent contamination. Even, if there is no production in these area, it is necessary to provide these utilities for the safety of process and product.
These utilities are different from basic ones such as electricity, and act as a support to maintain the required parameters of the environment. For example, to maintain acceptable temperature ranges, HVAC is used to maintain temperature and humidity in an area.
The energy requirements, among others, make the pharmaceutical industry a major consumer of energy and constitute a major balance expenditure.
Downtime
Downtimes, specifically unplanned, hits the production target very hard and affect the demand-supply ratio of an organization. It also affects the capability of an organization to deliver products on time.
Downtime affects the quality of products becau...
(All Rights Reserved)